eGenesis

eGenesis is developing genetically-engineered human-compatible organs for #transplantation 🧬🧬

[Inside Precision Medicine @Inside_PM]

Ep. 38 is live. @GrinsteinJ and @eGenesisBio’s Mike Curtis, PhD on how eGenesis kidney transplant cases are reframing xenotransplantation—not as a permanent solution, but as a bridge to a human transplant. https://t.co/MQcQYCH5Xb 
#BehindTheBreakthroughs #PrecisionMedicine

[Inside Precision Medicine @Inside_PM]

Ep. 38 of Behind the Breakthroughs: @GrinsteinJ and @eGenesisBio’s Mike Curtis, PhD on how recent kidney transplant cases are reshaping xenotransplantation—not as a permanent solution, but as a bridge to a human transplant.

https://t.co/athXYFxNc1
#BehindTheBreakthroughs

[Inside Precision Medicine @Inside_PM]

Mike Curtis: Pig Organs as a Bridge to Human Transplants

In this #BehindtheBreakthroughs episode, the @eGenesisBio president & CEO talks about scalable #clinicalxenotransplantation & how temporary life extensions can lead to future treatments
@GrinsteinJ
https://t.co/zdwxZkSRju

[eGenesis @eGenesisBio]

.@eGenesisBio has been named to @FastCompany’s list of the World’s Most Innovative Companies of 2026.

We’re No. 1 in the Biotech category and ranked No. 34 on Fast Company’s2026 World’s 50 Most Innovative Companies list.

Read our release: https://t.co/QpjDk8eazK

[Leonardo V. Riella @LVRiella]

🚀 Xenotransplantation named one of Nature’s 7 Innovations to Watch in 2026.
From CRISPR-edited pig organs to first-in-human success, it shows xeno moving from concept to clinical reality. @mgh_transplant @eGenesisBio
🧬🫀@Nature 👉https://t.co/LAFbE48GDx

[eGenesis @eGenesisBio]

Our CEO Mike Curtis joined a panel at the @Forbes Healthcare Summit on organ transplantation.

Watch the replay here:

https://t.co/orVou1wW8H

[Leaps by Bayer @LeapsByBayer]

@eGenesisBio is expanding beyond kidney 🩺, liver, and heart.🫀This tech could transform treatment for all solid organ failure.🎥 Watch: https://t.co/fsMMGkS4jY

[New Atlas @nwtls]

In a landmark move, the US Food and Drug Administration (FDA) has given biotech company eGenesis the go-ahead to conduct a broader human trial in pig-to-human kidney transplants, marking a significant step forward in addressing the critical organ shortage facing thousands of Americans.

https://t.co/C57gbNON2K

#Xenotransplantation #PigToHumanTransplant #OrganShortage #KidneyTransplant

[Kevin Longino @CEOatNKF]

Patients expressed strong support for the advancement of clinical trials in our recent Xenotransplantation Voice of the Patient report. It is gratifying to know they're being heard. Congratulates to eGenesis on this milestone! https://t.co/njie33Lw3j

[Lux Capital @Lux_Capital]

1/ Xenotransplantation has reached a major milestone: the @US_FDA approved the first human trials for pig kidney transplants, led by @eGenesisBio in the Lux family.

[Josh Wolfe @wolfejosh]

Huge news. Lux family co @eGenesisBio

[Danny Crichton @DannyCrichton]

Amazing what eGenesis has accomplished with xenotransplantation. Now with FDA clearance for clinical trials, we're getting closer to helping thousands waiting for kidney organs. Today, the company discussed patient no. 3 — Bill Stewart. More on CNN:
https://t.co/mzLvVpi5nh

[eGenesis @eGenesisBio]

.@AP covers our recent patient milestones and IND clearance for our kidney transplant program:

https://t.co/2Zwj6wMWsw

[eGenesis @eGenesisBio]

Thanks @CNN for covering our IND clearance and patient updates:

https://t.co/ZdfFhEyYZ4

[Jonathan D. Grinstein @GrinsteinJ]

When David Bennet Sr. received the first #CRISPR-edited pig heart in 2022, I was skeptical. Over the years, I've spoken with @eGenesisBio CEO Mike Curtis, PhD, several times, always impressed by his resolute precision—he's not selling snake oil. So, when I got to chat with Curtis last week to learn about the news that came out today with updates on the most recent kidney transplant recipients and on getting FDA clearance for clinical trials, I had two reactions. On the one hand, I was stunned because how can you not be stunned when someone goes from being on dialysis and in a wheelchair with no hope of survival to throwing the first pitch at a @RedSox game? On the other hand, it was Mike Curtis providing me with another unhyped update that is definitely worth the hype. As Curtis put it, “It's one of those things where it happens slowly and quickly.”

https://t.co/KXMFoUbuXM @Inside_PM

[Leonardo V. Riella @LVRiella]

We’re proud to share 3 historic breakthroughs @mgh_transplant
✅3rd kidney xenotransplant completed at MGH — patient thriving at 90 days
✅7+ months dialysis-free: longest survival w/ a pig kidney ever
✅FDA clears larger trial @eGenesisBio
@MGHMedicine @MGHSurgery @MGBKidneys

[Inside Precision Medicine @Inside_PM]

Gene-Edited Pig Kidney Xenotransplants Get IND Clearance for Clinical Trials

Plus updates from @eGenesisBio CEO Mike Curtis, PhD, on the dialysis-free progress of two patients with end-stage #kidneydisease that received #xenotransplants

#geneediting
https://t.co/zkoPbQrUFH

[STAT @statnews]

After two months with a kidney from a gene-edited Yucatan minipig named Lavender, a New Hampshire man is off dialysis. Soon, more people than ever will have pig organs. https://t.co/xD4PyvGluQ

[eGenesis @eGenesisBio]

We’re excited to announce IND Clearance for EGEN-2784 in Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study.

Release the release:
https://t.co/ShXP4CaDVE

#transplantation #kidney #biotech #hope

[eGenesis @eGenesisBio]

In June, I was at a Boston Red Sox game where 67-yr old Tim Andrews threw out the ceremonial 1st pitch. His liberty came in the form of having been free of dialysis for nearly 5 months after receiving a genetically edited pig kidney in January. - @MassBio

https://t.co/Jvpc1a9Qzb